These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6294350)

  • 21. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
    Ward JA; Robinson J; Furr BJ; Shalet SM; Morris ID
    Cancer Res; 1990 Feb; 50(3):568-74. PubMed ID: 2137024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic treatment with a potent luteinizing hormone releasing hormone agonist on serum luteinizing hormone and steroid levels in the male rhesus monkey.
    Resko JA; Belanger A; Labrie F
    Biol Reprod; 1982 Apr; 26(3):378-84. PubMed ID: 7044432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine studies with a gonadotropin-releasing hormone analogue to achieve withdrawal of testosterone in prostate carcinoma patients.
    Wenderoth UK; Happ J; Krause U; Adenauer H; Jacobi GH
    Eur Urol; 1982; 8(6):343-7. PubMed ID: 6814918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the pituitary-testicular function during experimental nephrosis.
    Menjívar M; Ortiz-López MG; Vilchis F; Díaz-Bonilla L; Zambrano E; Zariñán T; Pedraza-Chaverrí J
    Life Sci; 2002 Apr; 70(23):2769-82. PubMed ID: 12269381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.
    Auclair C; Kelly PA; Coy DH; Schally AV; Labrie F
    Endocrinology; 1977 Dec; 101(6):1890-3. PubMed ID: 201452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone.
    Redding TW; Coy DH; Schally AV
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1273-6. PubMed ID: 6803239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of infant and developing rat testicular gonadotropin and prolactin receptors and steroidogenesis by treatments with human chorionic gonadotropin, gonadotropin-releasing hormone analogs, bromocriptine, prolactin, and estrogen.
    Huhtaniemi IT; Warren DW; Catt KJ
    Biol Reprod; 1985 May; 32(4):721-32. PubMed ID: 2988657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
    Yano T; Pinski J; Szepeshazi K; Milovanovic SR; Groot K; Schally AV
    Prostate; 1992; 20(4):297-310. PubMed ID: 1351672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men.
    Faure N; Labrie F; Lemay A; Bélanger A; Gourdeau Y; Laroche B; Robert G
    Fertil Steril; 1982 Mar; 37(3):416-24. PubMed ID: 6800852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continued desensitization of the pituitary gland in young bulls after treatment with the luteinizing hormone-releasing hormone agonist deslorelin.
    Bergfeld EG; D'Occhio MJ; Kinder JE
    Biol Reprod; 1996 Apr; 54(4):769-75. PubMed ID: 8924495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary-testicular function is suppressed by an LHRH antagonist but not by an LHRH agonist in the marmoset monkey.
    Lunn SF; Dixson AF; Sandow J; Fraser HM
    J Endocrinol; 1990 May; 125(2):233-9. PubMed ID: 2165119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic D-Leu6, des-Gly10-gonadotropin releasing hormone ethylamide on male sex tissues.
    Rajfer J; Heber D; Peng S; Swerdloff RS
    Biol Reprod; 1984 Apr; 30(3):646-51. PubMed ID: 6426536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.
    Warner B; Worgul TJ; Drago J; Demers L; Dufau M; Max D; Santen RJ
    J Clin Invest; 1983 Jun; 71(6):1842-53. PubMed ID: 6408125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin.
    Belanger A; Auclair C; Seguin C; Kelly PA; Labrie F
    Mol Cell Endocrinol; 1979 Jan; 13(1):47-53. PubMed ID: 221286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.
    Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D
    J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
    Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
    Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of gonadotropin-releasing hormone receptor blockade on rat testicular gonadotropin and lactogen receptors, steroidogenesis, and responses to human chorionic gonadotropin stimulation.
    Huhtaniemi IT; Catt KJ
    Endocrinology; 1985 Jan; 116(1):281-7. PubMed ID: 2981066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.